A carregar...
An Improved Syngeneic Orthotopic Murine Model of Human Breast Cancer Progression
PURPOSE: Breast cancer drug development costs nearly $610 million and 37 months in preclinical mouse model trials with minimal success rates. Despite these inefficiencies, there are still no consensus breast cancer preclinical models. METHODS: Murine mammary adenocarcinoma 4T1-luc2 cells were implan...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4176514/ https://ncbi.nlm.nih.gov/pubmed/25200444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3118-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|